SCHEMBL9546211

SCHEMBL9546211

COC(=O)CCCCCC(O)C1C(=O)C2OC2C1C=CC(CCCCCO[SiH](C)C)C(C)(C)C

nearest known ligand 0.35

Predicted protein targets (top 5)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 2/20 0.35
▸ PTGER3 P43115 3/20 0.32
▸ PTGER4 P35408 2/20 0.32
▸ PPARA Q07869 1/20 0.32
▸ PTGER1 P34995 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9546461 0.80 TRPA1 (0.36) PPARGPPARA
SCHEMBL9546109 0.77 PPARG (0.30) PPARG
SCHEMBL9546383 0.76 PPARG (0.31) PPARGPPARA
SCHEMBL9546206 0.75 PPARG (0.38) PPARGPTGER3PTGER4PPARA
SCHEMBL9546204 0.74 PPARG (0.36) PPARGPTGER3PTGER4PPARA
SCHEMBL10620216 0.69 PTGIR (0.33) PPARGPPARA
SCHEMBL9546174 0.67 — —
SCHEMBL8909641 0.66 LTB4R (0.46) —
SCHEMBL11118818 0.65 TRPA1 (0.36) —
SCHEMBL7614865 0.65 TSHR (0.54) PPARG

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5216183-A Antitumor, anticarcinogenic agents; bone formation accelerators TEIJIN LIMITED (JP) 1993-06-01 — — US disclosed
EP-0338796-B1 2-SUBSTITUTED-2-CYCLOPENTENONES TEIJIN LIMITED (JP) 1993-03-10 — — EP disclosed
US-5116869-A Antitumor Agents, Bone Formation Accelerator TEIJIN LIMITED (JP) 1992-05-26 — — US disclosed
EP-0338796-A2 2-Substituted-2-cyclopentenones TEIJIN LIMITED (JP) 1989-10-25 — — EP disclosed
Send feedback